Roche pledges to extend commitment to the World Federation of Hemophilia Humanitarian Aid Program to 2028
- Details
- Category: Roche

Pfizer to acquire Biohaven Pharmaceuticals
- Details
- Category: Pfizer

Foundation S: Sanofi's new philanthropic spearhead
- Details
- Category: Sanofi

Pfizer shares top-line results from Phase 2/3 EPIC-PEP study of PAXLOVID™ for post-exposure prophylactic use
- Details
- Category: Pfizer

SK bioscience and GSK's adjuvanted COVID-19 vaccine candidate meets coprimary objectives in a phase III study
- Details
- Category: GlaxoSmithKline

Pfizer and Biohaven's VYDURA® (rimegepant) granted first ever marketing authorization by European Commission for both acute treatment of migraine and prophylaxis of episodic migraine
- Details
- Category: Pfizer

Novartis provides more than USD 25 million in medical aid to patients in Ukraine and bordering countries
- Details
- Category: Novartis

"As a medicines company, we have delivered more than one million packs of antibiotics, painkillers, cardiovascular, and oncology treatments which amounts to more than USD 25 million in medical aid to maintain the supply to those who rely on these drugs in Ukraine and in the border areas where people are seeking refuge."
More Pharma News ...
- Evusheld significantly protected against symptomatic COVID-19 for at least six months in PROVENT Phase III trial in high-risk populations
- GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn
- Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board
- Pfizer to acquire ReViral and its respiratory syncytial virus therapeutic candidates
- Novartis announces new organizational structure
- U.S. FDA grants priority review to Roche's Actemra/RoActemra for the treatment of COVID-19 in hospitalised adults
- Roche donates additional medicines and diagnostics for Ukraine